Drugs and Infodemic

Author:

Bravo Thais Ribeiro PintoORCID,Teixeira Rafaela Gomes da SilvaORCID,Elias Junior Alberto CalilORCID,Nogueira Thaisa AmorimORCID,Calil-Elias SabrinaORCID

Abstract

The first year of the COVID-19 pandemic brought critical scientific advances at speeds never seen before. The information from scientific studies won the world in news and social media. However, the spread of fake news provided an infodemic among a still unknown disease and no scientifically proven treatment. The present study aimed to evaluate the content and type of information on drugs indicated for the treatment of COVID-19 without scientific evidence in Brazilian social media. Two social media, Instagram and Twitter, were selected to search for drug information related to the prevention or treatment of COVID-19. The research was carried out using hashtags: #chloroquine, #hydroxychloroquine, #ivermectin, and #nitazoxanide for Portuguese publications in March 2020 and 2021. Descriptive statistic was used to present the quantitative data. In 2020, chloroquine was the drug with the highest number of publications in both social networks analyzed. The publications addressed the evidence of drug use and shortages, and the vast majority were considered correct information. While in 2021, ivermectin was the predominant drug cited on Instagram, while chloroquine was the most published on Twitter. Both drugs were related to “early treatment” and political and ideological content, classified as mostly disinformation. Thus, it is necessary to reinforce these social media guidelines to reduce the spread of health disinformation to the population. At the same time, health education in digital media is supported to ensure that the best information on management and care for COVID-19 reaches people and promotes their quality of life.

Publisher

Universidade Federal do Rio Grande do Norte - UFRN

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. Diabetes and Instagram: Analysis of Information in Brazilian Publications;Journal of Consumer Health on the Internet;2024-01-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3